Skip to content

Author

Xiao-Wen Lin

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Multi-omics and experimental validation identify RAPGEF2 as a protective prognostic biomarker in clear cell renal cell carcinoma

Highlights • Single-cell, spatial transcriptomic and multi-omics analyses reveal endothelial-enriched RAPGEF2 in KIRC.• RAPGEF2 independently predicts favorable survival across multicenter KIRC cohorts.• Experimental validation links RAPGEF2 to tumor suppression and immunotherapy benefit.

Yan-Fei Chen, Xiao-Xue Yu, Chao Cai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.